◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states ◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states
Home / Formulary / PT-141
Back to formulary
PT-141 — LORIUM lyophilised vial LORIUM · 10 mg LYOPHILISED VIAL
Third-party tested · COA included with every lot
Vitality ● In stockPrescription required

PT-141

Melanocortin agonist

PT-141 is an advanced melanocortin receptor agonist engineered to enhance sexual function and desire through targeted neurological pathways rather than localized vascular dilation. By directly activating specific centers within the central nervous system, this premium protocol safely stimulates natural arousal, heightens intimacy motivation, and supports performance confidence.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It is dispensed only pursuant to a valid prescription following evaluation by a licensed provider.

Researched effects

Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.

Enhanced Sexual Desire

Significantly increases libido, sexual motivation, and arousal in both men and women.

Neurological Performance Support

Enhances baseline erectile and reproductive performance via direct CNS activation.

Advanced Aphrodisiac Effects

Heightens intrinsic sexual drive through targeted melanocortin pathway stimulation.

Non-Vascular Efficacy

High success rate even for individuals non-responsive to traditional vascular therapies.

Rapid Activation

Fast onset of action within ~30 minutes post-application.

Vascular Independence

Functions independently of nitric oxide pathways.

Premium Safety Profile

Minimal systemic side effects without significant impacts on blood pressure or heart rate.

Specifications

ClassMelanocortin agonist
CAS number189691-06-3
Molar mass1025.2 g/mol
Available sizes10 mg
AdministrationAdvanced subcutaneous protocol for targeted vitality.
CategoryVitality
View a sample certificate of analysis →

Clinical references

  1. Khera, M., et al. (2016). Bremelanotide (PT-141) for the treatment of hypoactive sexual desire disorder in women. Journal of Sexual Medicine, 13(9), 1367–1374.
  2. Sharma, S., et al. (2017). Efficacy and safety of bremelanotide in the treatment of female sexual dysfunction. International Journal of Impotence Research, 29(4), 113–119.
  3. Carter, D., et al. (2020). The role of melanocortin peptides in sexual arousal and function. American Journal of Clinical and Experimental Urology, 47(6), 2269–2277.
Related

More in Vitality

View all →